Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer.

Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. · 2017

Read Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. by Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5297828.txt.

Description

Inés Mármol, Cristina Sánchez-de-Diego, Alberto Pradilla Dieste, Elena Cerrada, and María Jesús Rodriguez Yoldi surveyed colorectal cancer in the International Journal of Molecular Sciences in 2017. It is the third most common cancer and fourth commonest cause of cancer death, with lifetime risk around 4 to 5 percent, rising in Western countries. Age, chronic disease, and lifestyle all feed the risk.

The review explains the disease's machinery. Gut microbe imbalance can drive chronic inflammation that seeds cancer, with Fusobacterium, Bacteroides fragilis, and pathogenic E. coli among the suspects. Cases split into sporadic (70 percent), familial (25 percent), and inherited (5 percent), arising through chromosomal instability, microsatellite instability, or a methylator pattern. Mutations in genes such as KRAS, BRAF, and PIK3CA now serve as markers guiding prognosis and drug choice. Standard care is surgery plus chemotherapy, increasingly paired with targeted antibodies; newer options include probiotics and gold-based drugs.

Catalog record

CREATORMármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE137 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5297828

Browse the full library · About the Tower of Babel